Johannes Lind-Widestam steps down as CEO of Elos Medtech

Johannes Lind-Widestam has decided to vacate his position as President and Chief Executive Officer of Elos Medtech. He will remain in his current position during his period of notice and leave the company at midyear. The process of finding a successor for Johannes starts immediately.

“We thank Johannes for the time he has worked as Chief Executive Officer of Elos Medtech,” says Stig-Arne Blom, Chairman of the Elos Medtech Board. “It is regrettable that he is leaving our group. Among his accomplishments, Johannes has contributed to the acquisition of our American subsidiary, Onyx Medical. He has also admirably continued to drive the development of the Group towards becoming a dedicated player in the global medical technology market.”

“It is gratifying to have been a part of Elos Medtech and the expansion process that is under way. I am convinced that in the future too the Group will continue to successfully focus on growth,” says Johannes Lind-Widestam.
 

Elos Medtech is one of Europe's leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are internationally active medical technology companies.

Elos Medtech Group’s turnover is approximately MSEK 550 and has about 520 employees. The Group has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.

Lidköping, 20 January 2016

Elos Medtech AB (publ)

For further information, please contact: Stig-Arne Blom, Chairman of the Board, phone 46 705 25 16 15, e-mail stigarne@blom.pp.se 

The information in this press release is such that Elos Medtech AB is obligated to publish in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was issued for publication on 20 January 2016, at 08:00 a.m. (CET).

For additional information visit www.elosmedtech.com 

Tags: